These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Clinical efficacy of WT1 peptide vaccination in patients with acute myelogenous leukemia and myelodysplastic syndrome. Yasukawa M; Fujiwara H; Ochi T; Suemori K; Narumi H; Azuma T; Kuzushima K Am J Hematol; 2009 May; 84(5):314-5. PubMed ID: 19338044 [No Abstract] [Full Text] [Related]
28. On the road to a tumor cell vaccine: 20 years of cellular immunotherapy. Yannelli JR; Wroblewski JM Vaccine; 2004 Nov; 23(1):97-113. PubMed ID: 15519713 [TBL] [Abstract][Full Text] [Related]
31. Dendritic cells in cancer immunotherapy. Vulink A; Radford KJ; Melief C; Hart DN Adv Cancer Res; 2008; 99():363-407. PubMed ID: 18037410 [TBL] [Abstract][Full Text] [Related]
32. [Immunology in medical practice. XXV. Use of dendritic cells in the immunotherapy of cancer]. Punt CJ; de Vries IJ; Mulders PF; Adema GJ; Figdor CG Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2408-14. PubMed ID: 10608974 [TBL] [Abstract][Full Text] [Related]
33. Immunotherapy with dendritic cells for cancer. Ballestrero A; Boy D; Moran E; Cirmena G; Brossart P; Nencioni A Adv Drug Deliv Rev; 2008 Jan; 60(2):173-83. PubMed ID: 17977615 [TBL] [Abstract][Full Text] [Related]
34. The novel bispecific diabody alphaCD40/alphaCD28 strengthens leukaemic dendritic cell-induced T-cell reactivity. Houtenbos I; Santegoets S; Westers TM; Waisfisz Q; Kipriyanov S; Denkers F; Scheper RJ; de Gruijl TD; Ossenkoppele GJ; van de Loosdrecht AA Br J Haematol; 2008 Jun; 142(2):273-83. PubMed ID: 18492117 [TBL] [Abstract][Full Text] [Related]
35. Dendritic cells as therapeutic vaccines against cancer. Banchereau J; Palucka AK Nat Rev Immunol; 2005 Apr; 5(4):296-306. PubMed ID: 15803149 [TBL] [Abstract][Full Text] [Related]
36. Personalized cancer vaccines. Jain KK Expert Opin Biol Ther; 2010 Dec; 10(12):1637-47. PubMed ID: 20979567 [TBL] [Abstract][Full Text] [Related]
37. Leukemia-derived dendritic cells: towards clinical vaccination protocols in acute myeloid leukemia. Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA Haematologica; 2006 Mar; 91(3):348-55. PubMed ID: 16531258 [TBL] [Abstract][Full Text] [Related]
38. Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease. Tsuboi A; Oka Y; Kyo T; Katayama Y; Elisseeva OA; Kawakami M; Nishida S; Morimoto S; Murao A; Nakajima H; Hosen N; Oji Y; Sugiyama H Leukemia; 2012 Jun; 26(6):1410-3. PubMed ID: 22157809 [No Abstract] [Full Text] [Related]
39. Global sensitivity analysis and model-based reactive scheduling of targeted cancer immunotherapy. Kiran KL; Lakshminarayanan S Biosystems; 2010 Aug; 101(2):117-26. PubMed ID: 20639123 [TBL] [Abstract][Full Text] [Related]